As of 2024-12-12, the Relative Valuation of Prelude Therapeutics Inc (PRLD) is (65.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.94 USD, the upside of Prelude Therapeutics Inc based on Relative Valuation is -7115.9%.
The range of the Relative Valuation is (67.24) - (70.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 40.9x | 34.7x |
| Forward P/E multiples | 19.8x - 29.5x | 20.5x |
| Fair Price | (67.24) - (70.59) | (65.95) |
| Upside | -7253.2% - -7609.1% | -7115.9% |
| Date | P/E |
| 2024-12-10 | -0.41 |
| 2024-12-09 | -0.43 |
| 2024-12-06 | -0.40 |
| 2024-12-05 | -0.39 |
| 2024-12-04 | -0.40 |
| 2024-12-03 | -0.41 |
| 2024-12-02 | -0.44 |
| 2024-11-29 | -0.44 |
| 2024-11-27 | -0.44 |
| 2024-11-26 | -0.41 |
| 2024-11-25 | -0.40 |
| 2024-11-22 | -0.40 |
| 2024-11-21 | -0.40 |
| 2024-11-20 | -0.40 |
| 2024-11-19 | -0.40 |
| 2024-11-18 | -0.39 |
| 2024-11-15 | -0.44 |
| 2024-11-14 | -0.43 |
| 2024-11-13 | -0.44 |
| 2024-11-12 | -0.48 |
| 2024-11-11 | -0.50 |
| 2024-11-08 | -0.50 |
| 2024-11-07 | -0.53 |
| 2024-11-06 | -0.55 |
| 2024-11-05 | -0.54 |
| 2024-11-04 | -0.50 |
| 2024-11-01 | -0.52 |
| 2024-10-31 | -0.50 |
| 2024-10-30 | -0.55 |
| 2024-10-29 | -0.60 |
| 2024-10-28 | -0.63 |
| 2024-10-25 | -0.64 |
| 2024-10-24 | -0.65 |
| 2024-10-23 | -0.69 |
| 2024-10-22 | -0.74 |
| 2024-10-21 | -0.74 |
| 2024-10-18 | -0.80 |
| 2024-10-17 | -0.80 |
| 2024-10-16 | -0.81 |
| 2024-10-15 | -0.80 |
| 2024-10-14 | -0.81 |
| 2024-10-11 | -0.82 |
| 2024-10-10 | -0.81 |
| 2024-10-09 | -0.80 |
| 2024-10-08 | -0.85 |
| 2024-10-07 | -0.83 |
| 2024-10-04 | -0.84 |
| 2024-10-03 | -0.79 |
| 2024-10-02 | -0.85 |
| 2024-10-01 | -0.85 |